Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWAzlocillin is a semisynthetic acylureidopenicillin with broad spectrum antibacterial properties.1,2 Like the structurally related antibiotics mezlocillin and piperacillin (Item no. 20766), azlocillin is effective against the Enterobacteriaceae, including strains of K. pneumoniae that are resistant to older penicillins.3 Azlocillin is part of antibiotic cocktails known as PANTA (with polymyxin B (Item No. 14157)), amphotericin B (Item No. 11636), nalidixic acid (Item No. 19807), and trimethoprim (Item No. 16473) and PANTAV (PANTA with vancomycin (Item No. 15327)).4 Azlocillin is also effective against the malarial parasite P. falciparum at concentrations similar to those used during antibiotic therapy.5
WARNING This product is not for human or veterinary use.
1. Azlocillin: In vitro studies of a new semisynthetic penicillin. Antimicrob. Agents Chemother. 11(5), 865-870 (2015).
2. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob. Agents Chemother. 15(4), 540-543 (1979).
3. Azlocillin, mezlocillin, and piperacillin: New broad-
4. Comparison of culture methods for isolation of nontuberculous mycobacteria from surface waters. Appl. Environ. Microbiol. 76(11), 3514-3520 (2010).
5. Searching for new antimalarial therapeutics amongst known drugs. Chem. Biol. Drug Des. 67(6), 409-416 (2006).